ProteinQure

ProteinQure

Private
TorontoHealthcare & Life Scienceshttps://proteinqure.com

Last Round

Grant

Apr 7, 2026

Total Funding Raised

$17.71M

Momentum Score

25 /100

Company Overview

ProteinQure is a biotechnology company that has developed a computational platform for the design of peptide-based therapeutics using quantum computing, artificial intelligence, and molecular dynamics simulations.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Application

Keywords

peptide therapeuticsAI drug discoverycomputational drug designtechbioAI biotechprotein designAI drug discovery platformin silico drug discoverygenerative biologyde novo peptide designclinical-stage biotechbiopharma partnershipspeptide-drug conjugatemolecular simulationsoncology therapeuticslead optimization

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProteinQure Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ProteinQure Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantApr 7, 2026
Series AMay 28, 2025
GrantJan 21, 2025
GrantFeb 22, 2024
SeedJul 25, 2019

Key People

Founding team and executive leadership

Christopher Ing

Co-Founder And Chief Scientific Officer

Founding Team

Mark Fingerhuth

Co-Founder And Chief R D Officer

Founding Team

Tomas Babej

Cofounder And Chief Technology Officer

Founding Team

Lucas Siow

Co-Founder - CEO

Founding Team

ProteinQure Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    $1.86M grant received

  • May 28, 2025

    $11M round completed.

ProteinQure Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ProteinQure Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ProteinQure's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range32
Year Founded2017
Last FundingApr 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.